Precipio (PRPO) Stock Price, News & Analysis

Company Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Key Stats

• Today's Range: $9.45 to $10.74
• 50-Day Range: $5.05 to $10.14
• 52-Week Range: $4.31 to $10.74
• Volume: 77,637 shs
• Average Volume: 11,816 shs
• Market Capitalization: $15.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PRPO Stock Analysis - Frequently Asked Questions

How have PRPO shares performed this year?

Precipio's stock was trading at $5.54 at the beginning of the year. Since then, PRPO shares have increased by 83.0% and is now trading at $10.14.
View the best growth stocks for 2025 here.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings data on Wednesday, November, 6th. The biotechnology company reported ($0.42) EPS for the quarter. The biotechnology company earned $5.21 million during the quarter. Precipio had a negative net margin of 17.23% and a negative trailing twelve-month return on equity of 34.01%.

When did Precipio's stock split?

Precipio's stock reverse split before market open on Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are Precipio's major shareholders?

Top institutional shareholders of Precipio include Renaissance Technologies LLC (0.68%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Richard A Sandberg, Ilan Danieli and Ahmed Zaki Sabet.
View institutional ownership trends.

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and General Electric (GE).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 2/21/2025
• Next Earnings (Estimated): 4/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:PRPO
• CUSIP: N/A
• CIK: 1043961
• Web: www.precipiodx.com
• Phone: (203) 787-7888
• Fax: 402-452-5401
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.83)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-5,850,000.00
• Net Margins: -17.23%
• Pretax Margin: -17.23%
• Return on Equity: -34.01%
• Return on Assets: -25.27%

Debt

• Debt-to-Equity Ratio: 0.02
• Current Ratio: 0.73
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: $15.20 million
• Price / Sales: 0.99
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $10.16 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 1,480,000
• Free Float: 1,285,000
• Market Cap: $15.01 million
• Optionable: No Data
• Beta: 1.42